Promega Corporation

GoScript™ Reverse Transcriptase

GoScript™ Reverse Transcriptase utilizes M-MLV and state-of-the-art buffer technology designed for qPCR to deliver robust, reliable cDNA synthesis of a full range of rare and abundant transcripts, even in the presence of inhibitors. GoScript™ Reverse Transcriptase is qualified for use in qPCR, including GoTaq® qPCR and Plexor® qPCR systems for performing RT-qPCR.

Expand to Read More »

  • Share
  • Print
  • Email
  • Products
  • Specifications
  • Figures & Tables
  • Product Resources
  • Patents & Disclaimers
  • Prices valid for your Promega branch only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart

GoScript™ Reverse Transcriptase

Close Window

GoScript™ Reverse Transcriptase

 Components

  • MgCl2

    A351H1 x 1.2ml
  • GoScript™ 5X Reaction Buffer

    A500C1 x 600μl
  • GoScript™ Reverse Transcriptase

    A501C1 x 100μl
100 reactions
- A5003 $ 140.00 Add to cart

GoScript™ Reverse Transcriptase

Close Window

GoScript™ Reverse Transcriptase

 Components

  • MgCl2

    A351H3 x 1.2ml
  • GoScript™ 5X Reaction Buffer

    A500D2 x 1.25ml
  • GoScript™ Reverse Transcriptase

    A501D1 x 500μl
500 reactions
- A5004 $ 541.00 Add to cart


You Also May Be Interested In

Storage Conditions

Store at –20°C.

For product intended use please see Patents & Disclaimers tab.

Figures

GoScript Reverse Transcriptase cDNA synthesis coupled with GoTaq qPCR Master Mix can provide detection of input templates over a 9-log order dynamic range.Figure 1. GoScript™ Reverse Transcriptase cDNA synthesis coupled with GoTaq® qPCR Master Mix can provide detection of input templates over a 9-log order dynamic range.

/~/media/Images/Resources/Figures/8600-8699/8645TA_550px.ashx

Use Restrictions

A5003, A5004 For Laboratory Use. Outside of the United States, this product is intended for research use only unless otherwise stated.

Patents - Disclaimers

U.S. Pat. No. 6,242,235, Australian Pat. No. 761757, Canadian Pat. No. 2,335,153 and other patents and patents pending.

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.